MK-8527
8527-011
Phase 3 small_molecule active
Quick answer
MK-8527 for Human Immunodeficiency Virus (HIV) is a Phase 3 program (small_molecule) at Merck KGaA, Darmstadt, Germany with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck KGaA, Darmstadt, Germany
- Indication
- Human Immunodeficiency Virus (HIV)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active